FBInvestor
Stocks / Okyo Pharma Ltd
Institutional Ownership

Okyo Pharma Ltd

CUSIP G6724L116SHS NEWOKYOQ1 2026

13D / 13G Filings
9
Schedule 13D/13G on record
Beneficial Filers
4
Distinct reporting persons
Largest Stake
9.5%
Max % of class reported
Institutional Holders
12
13F filers (latest quarter)

Beneficial Owners — Schedule 13D / 13G

9 filings · latest Feb 18, 2026

Export CSV — Pro
#FiledReporting PersonForm% of ClassSharesFiling
1Feb 18, 2026Point72 Asset Management, L.P.13G7.9%4.06MSEC
2Feb 13, 2026Chernett Jorey13G/A9.5%3.80MSEC
3Feb 12, 2026Dauntless Investment Group, LLC13G/A1.2%471.5KSEC
4Nov 14, 2025Dauntless Investment Group, LLC13G/A6.3%2.42MSEC
5Nov 14, 2025Chernett Jorey13G/A7.8%2.98MSEC
6Oct 29, 2025Laura Natalia Monica Fonda13G5.0%1.93MSEC
7Aug 5, 2025Dauntless Investment Group, LLC13G/A7.3%2.74MSEC
8May 27, 2025Chernett Jorey13G6.8%2.30MSEC
9Mar 18, 2025Dauntless Investment Group, LLC13G5.9%2.00MSEC

Top Institutional Holders (13F)

Largest reported positions · latest quarter

View all →